Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Oculoplastics > Vitamin A palmitate eye gel, sodium hyaluronate eye drop improves dry eye in patients with TED
  • Oculoplastics

Vitamin A palmitate eye gel, sodium hyaluronate eye drop improves dry eye in patients with TED

Ophthalmology 360

Amongst patients with thyroid eye disease (TED) experiencing dry eye syndrome, use of a vitamin A palmitate gel was found to improve tear film stability and a sodium hyaluronate eye drop resulted in improvements in discomfort, according to a study.

Patients in this study had inactive mild or moderate-to-severe TED with dry eye syndrome and were randomly divided to receive vitamin A palmitate eye gel 3 times/day for 1 month or sodium hyaluronate eye drops.

A total of 80 patients started the trial, of which 64 completed treatment. At baseline, there were no significant differences between the groups.

In eyes treated with the gel there was a significant improvement in break-up time and corneal fluorescence staining grade (effective rate = 91.2%) and in eyes treated with the drops, there was significant improvement in ocular surface disease index score and corneal fluorescence staining grade (effective rate = 67.7%). Break-up time was also significantly longer in the group treated with gel than in the group treated with drops.

Reference
Sun R, Yang M, Lin C, et al. A clinical study of topical treatment for thyroid-associated ophthalmopathy with dry eye syndrome. BMC Ophthalmol. 2023;23(1):72. doi: 10.1186/s12886-023-02805-8. PMID: 36803227.

Share

Related Content

Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
  • Cornea and External Disease

Preventing complications of superficial keratectomy

  • Oculoplastics

Blepharoplasty candidates prioritize function over aesthetics, survey finds

  • Oculoplastics

Integrating amniotic allografts into modern oculoplastic reconstruction: a practical perspective

  • The Ophthalmic Project

The next generation of amniotic membranes for the treatment of corneal epithelial defects

  • Oculoplastics

Can ChatGPT-4 respond accurately to common blepharoplasty questions?

2 Mins Read
  • Oculoplastics

Study examines preoperative anxiety and knowledge in patients undergoing blepharoplasty

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon